18th Biennial International Andreas Gruentzig Society Meeting

These proceedings summarize the educational activity of the 18th Biennial Meeting of the International Andreas Gruentzig Society held January 27 to 30, 2026, in Puerto Ayora, Santa Cruz, Ecuador.

Faculty Disclosures     Sponsors

2026 IAGS Summary Document

Program Agenda

Session 1: Coronary 1 - Elective PCI

1.1  DCB's for De Novo Coronary Lesions: Which Lesions and Is the Provisional Approach to PCI Back?

1.2  ISR: Are DCBs Now the Answer?

1.3  The Alphabet Soup of Plaque Modification: CB, RA, OA, IVL. Real or Imagined? Will SONAR Provide Insight? Are Novel Approaches Needed?

Session 2: Structural 1 - Aortic Valve

2.1  EARLY TAVR: Sure. Moderate AS: Not So Sure?

2.2  TAVR for Aortic Insufficiency: ALIGNed for the Future but Are We Ready for ARTIST?

2.3  Issues Facing TAVR: Lifetime Management and How to Handle the Volume with Expanding Indications in an Aging Population

Session 3: Endovascular 1

3.1  Advances in Infrainguinal Interventions for Claudicants: Data Supporting Best Applications for DCBs, DES and Endografts

3.2  Most Effective Interventions for CLI: A Critical Appraisal

3.3  Carotid Stenting Following CREST-2: How to Democratize and do Micromesh Stents and TCAR Have a Role?

Session 4: Coronary 2 - STEMI

4.1  COMPLETE, MULTISTARS, BIOVASC and OPTION: Enough Evidence to Standardize STEMI PCI Worldwide?

4.2  STEMI-CS: Any "DanGer" to Unloading Routinely? Complete or CULPRIT Revascularization? Are Shock Teams Needed? How to Handle the Antiplatelet/Anticoagulation Therapy?

4.3  Minimizing Infarct Size in STEMI: Latest Techniques, Pharmacology and How to Manage Microvascular Obstruction

Session 5: Structural Session 2 - Mitral and Tricuspid Valve

5.1  TMVR vs. TMVr: Is TMVR There Yet? When to do TMVr Instead and With What

5.2  Interventional Solutions for TR: Any Room for More "T's" (Triapta, Tricvalve, Trillium) or "C's" (Cormaze, Cardioband) and How to Factor Pacemakers, RV Dysfunction

5.3  Best Practices for Closure of Large Bore Arterial and Venous Access Sites for Structural Interventions

Session 6: Structural 3 - Atrial & Ventricular

6.1  LAA Occlusion: The Best OPTION and how to CHAMPION the Procedural Volume

6.2  Interventional Strategies for HFrEF: Shunt the Atrium or Squeeze the Muscle(s)?

6.3  Strategies for HFpEF: Mavacamten, SESAME, PIMSRA, or More Shunts?

Session 7: Hemodynamics

7.1  ECMO-PCI for Cardiac Arrest: Trending, but in Whom and When is it Futile? Do ECMO Devices need to be Improved?

7.2  Circulatory Support for Cardiogenic Shock: Matching the Device Strategy to the Patient for Best Outcomes

7.3  Chronic Pulmonary Hypertension: Is POBA Enough for CTEPH? Embolectomy? And What About Denervation?

Session 8: Endovascular 2

8.1  Managing Complex Aortic and Iliac Occlusive Disease

8.2  Bioresorbable Scaffolds for Vascular Interventions: Is it Time to Move Up or Stay BTK?

8.3  Peripheral Atherectomy: Under or Over Utilized? Where is the Data Showing Benefit?

Session 9: Emerging Therapies

9.1  Renal Denervation: Comparison of Therapeutic Approaches, Efficacy, Adoption and Reimbursement

9.2  Combined Imaging/Physiology Catheters: Devices Everyone Should Have and Use and How AI will Make Them Even Better

9.3  Uncaging Coronary Artery Aneurysms: Have we Made Progress and Which Ones to Treat?

Session 10: Interventional Laboratory

10.1  Diagnosing ANOCA/INOCA and Treating MINOCA in the Interventional Laboratory

10.2  Left Main PCI: New Life Following a NOBLE Effort?

10.3  Radiation Safety in the Interventional Laboratory

Session 11: Health Care Delivery

11.1  Artificial Intelligence in Interventional Medicine: Beyond Imaging to Procedures. Where are we Headed?

11.2  Joint Position Statement of the ACC, IAGS and SCAI: Addressing the Cardiovascular Risk Factors of Obesity and Inflammation

11.3  Joint Position Statement of the ACC, IAGS and SCAI: The American Board of Cardiovascular Medicine